BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34418466)

  • 1. Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency Study.
    Corry J; Ng WT; Moore A; Choi HCW; Le Q; Holmes S; Munandar A; Wang S; Camacho A; Setakornnukul J; Jiarpinitnun C; Hiep PN; Laskar SG; Benjaafar N; Faheem M; Jin F; Ammar CNB; Ali R; Boualga K; Abdelwahab S; Sommat K; Tao Y; O'Sullivan B; Lee N; Zubizaretta E; Prajogi B; Hopkins K; Rosenblatt E; Lee AWM
    Int J Radiat Oncol Biol Phys; 2021 Dec; 111(5):1227-1236. PubMed ID: 34418466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.
    Boustani J; Rivin Del Campo E; Blanc J; Peiffert D; Benezery K; Pereira R; Rio E; Le Prisé E; Créhange G; Huguet F
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):329-337. PubMed ID: 31299242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance of the jaws only-intensity modulated radiation therapy plans for head-and-neck cancer.
    Tai DT; Son ND; Loan TTH; Anson HPW
    Phys Med; 2017 Jun; 38():148-152. PubMed ID: 28571708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Practice of Paediatric Radiation Oncology in Low- and Middle-income Countries: Outcomes of an International Atomic Energy Agency Study.
    Anacak Y; Zubizarreta E; Zaghloul M; Laskar S; Alert J; Gondhowiardjo S; Giselvania A; Correa-Villar R; Pedrosa F; Dorj B; Kamer S; Howard SC; Quintana Y; Ribeiro RC; Rosenblatt E; Hopkins K
    Clin Oncol (R Coll Radiol); 2021 Apr; 33(4):e211-e220. PubMed ID: 33250288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis.
    Sun WZ; Zhang DD; Peng YL; Chen L; Kang DH; Wang B; Deng XW
    Radiat Oncol; 2018 Mar; 13(1):42. PubMed ID: 29544512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
    Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intensity-modulated radiotherapy using helical tomotherapy and segmental multileaf collimator-based techniques for nasopharyngeal carcinoma: dosimetric analysis incorporating quality assurance guidelines from RTOG 0225.
    Chen A; Lee N; Yang C; Liu T; Narayan S; Vijayakumar S; Purdy J
    Technol Cancer Res Treat; 2010 Jun; 9(3):291-8. PubMed ID: 20441239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
    Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
    Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
    Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
    Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
    Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
    Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
    Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.
    Hung HM; Chan OCM; Mak CH; Hung WM; Ng WT; Lee MCH
    Med Dosim; 2022 Spring; 47(1):14-19. PubMed ID: 34470708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
    Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single arc volumetric-modulated arc therapy is sufficient for nasopharyngeal carcinoma: a dosimetric comparison with dual arc VMAT and dynamic MLC and step-and-shoot intensity-modulated radiotherapy.
    Ning ZH; Mu JM; Jin JX; Li XD; Li QL; Gu WD; Huang J; Han Y; Pei HL
    Radiat Oncol; 2013 Oct; 8():237. PubMed ID: 24125432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The International Atomic Energy Agency global initiatives on nasopharyngeal cancer treatment.
    Lam KO; Lee AW; Ng WT; Hopkins KI
    Chin Clin Oncol; 2016 Apr; 5(2):27. PubMed ID: 27121887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Radiation Therapy Quality Assurance on Nasopharyngeal Carcinoma: Usage of a Novel, Web-Based Quality Assurance Application.
    Kim JW; Marsilla J; Kazmierski M; Tkachuk D; Huang SH; Xu W; Cho J; Ringash J; Bratman S; Haibe-Kains B; Hope A
    Pract Radiat Oncol; 2023; 13(4):e354-e364. PubMed ID: 36948414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
    Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
    Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.